Number of positive cells counted | Ratio between treated and control groups | ||||||
---|---|---|---|---|---|---|---|
 | Cleaved PARP | Caspase-3 | Cytosolic cytochrome-c |  | Cleaved PARP | Caspase-3 | Cytosolic cytochrome-c |
C16 | 43.1 ± 7.1a | 3.7 ± 0.4a | 3.4 ± 0.3a |  |  |  |  |
W16 | 136.7 ± 12.2b | 16.0 ± 1.4c | 4.7 ± 0.3a | W16/C16 | 2.89 ± 0.30a | 3.02 ± 0.37a | 1.52 ± 0.11a |
A16 | 71.7 ± 9.2c | 7.9 ± 0.4c | 6.7 ± 0.4c | A16/C16 | 1.41 ± 0.13b | 2.90 ± 0.35a | 2.54 ± 0.25b |
C19 | 48.0 ± 5.9a | 1.3 ± 0.2b | 4.9 ± 0.3a |  |  |  |  |
W19 | 149.2 ± 20.9b | 9.3 ± 0.7c | 13.3 ± 0.7b | W19/C19 | 3.40 ± 0.23a | 7.56 ± 0.74b | 3.03 ± 0.20b |
A19 | 115.9 ± 9.5b | 4.6 ± 0.2a | 15.4 ± 0.4d | A19/C19 | 3.00 ± 0.30a | 3.84 ± 0.34a | 3.35 ± 0.21b |
C21 | 54.8 ± 7.6a | 2.5 ± 0.3a | 4.8 ± 0.3a |  |  |  |  |
W21 | 148.0 ± 16.9b | 7.3 ± 0.7c | 12.7 ± 0.6b | W21/C21 | 2.99 ± 0.54a | 2.50 ± 0.70a | 3.00 ± 0.22b |
A21 | 73.4 ± 11.7c | 7.2 ± 0.4c | 10.2 ± 0.6b | A21/C21 | 1.67 ± 0.36b | 2.43 ± 0.50a | 2.78 ± 0.29b |